CD73 Inhibitor Shows Promise as Part of Combination Therapy for Metastatic Pancreatic Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 13
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 5
Results: 19
1
2
Belzutifan: A New Approach to Treating Advanced Clear-Cell Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 1
- By:
- Publication type:
- Article
3
FDA Approves Trodelvy for the Treatment of Locally Advanced or Metastatic Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 34
- Publication type:
- Article
4
Opdivo Now Approved in Combination with Chemotherapy for Advanced or Metastatic Gastric Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 33
- Publication type:
- Article
5
FDA Approves Abecma, First CAR T-Cell Therapy for Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 33
- Publication type:
- Article
6
Jemperli Approved for Patients with Recurrent or Advanced dMMR Endometrial Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 32
- Publication type:
- Article
7
FDA Approves Zynlonta for Relapsed or Refractory Large B-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 32
- Publication type:
- Article
8
E/M Guideline Changes and Legislative Updates: What Practices Need to Know.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 29
- By:
- Publication type:
- Article
9
Bispecific Antibodies Show Encouraging Activity in Heavily Pretreated Patients with Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 28
- By:
- Publication type:
- Article
10
Pevonedistat plus Azacitidine Combination Improves Outcomes in Higher-Risk MDS.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 26
- By:
- Publication type:
- Article
11
Sacituzumab Govitecan Shows Promise for Heavily Pretreated Patients with Metastatic TNBC and Brain Metastases.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 24
- By:
- Publication type:
- Article
12
Physicians May Underestimate the Severity of Radiation-Associated Symptoms in Some Patients with Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 22
- By:
- Publication type:
- Article
13
The Intersection of Precision Medicine and Data Analysis in the Community Oncology Setting.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 20
- By:
- Publication type:
- Article
14
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 17
- By:
- Publication type:
- Article
15
Pandemic Has Resulted in Later Diagnoses, Worse Outcomes for Patients with Lung Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 16
- By:
- Publication type:
- Article
16
Addition of Bemarituzumab to Chemotherapy Improves Survival in Patients with FGFR2b- Positive Advanced Gastric Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 12
- By:
- Publication type:
- Article
17
Genomic Analysis Identifies EGFR as the Most Common Mutation in Women with Lung Cancer and No Smoking History.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 11
- By:
- Publication type:
- Article
18
Addressing Lung Cancer Screening Disparities in LGBT Populations.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 1
- By:
- Publication type:
- Article
19
Nivolumab Improves Survival in Patients with Relapsed Malignant Mesothelioma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 5, p. 1
- By:
- Publication type:
- Article